Carmichael Hill & Associates’s Eterna Therapeutics ERNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-5
| Closed | -$170 | – | 695 |
|
|
2023
Q2 | $170 | Hold |
5
| – | – | ﹤0.01% | 670 |
|
|
2023
Q1 | $255 | Hold |
5
| – | – | ﹤0.01% | 662 |
|
|
2022
Q4 | $242 | Hold |
5
| – | – | ﹤0.01% | 649 |
|
|
2022
Q3 | $0 | Hold |
5
| – | – | ﹤0.01% | 726 |
|
|
2022
Q2 | $1K | Hold |
5
| – | – | ﹤0.01% | 648 |
|
|
2022
Q1 | $3K | Hold |
5
| – | – | ﹤0.01% | 608 |
|
|
2021
Q4 | $6K | Buy |
+5
| New | +$6K | ﹤0.01% | 562 |
|